Robin Uchiyama

ORCID: 0000-0003-3983-286X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Viral gastroenteritis research and epidemiology
  • Pediatric health and respiratory diseases
  • Clostridium difficile and Clostridium perfringens research
  • IL-33, ST2, and ILC Pathways
  • Child Nutrition and Water Access
  • Tuberculosis Research and Epidemiology
  • Infant Nutrition and Health
  • COVID-19 Clinical Research Studies
  • Respiratory viral infections research
  • Hepatitis Viruses Studies and Epidemiology
  • Gut microbiota and health
  • Animal Virus Infections Studies
  • Mycobacterium research and diagnosis
  • Diet, Metabolism, and Disease
  • Pneumonia and Respiratory Infections
  • Immune Response and Inflammation
  • Epigenetics and DNA Methylation
  • Liver Disease Diagnosis and Treatment
  • Amoebic Infections and Treatments
  • Learning Styles and Cognitive Differences
  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 detection and testing

Qiagen (United States)
2021

University of Virginia Health System
2018

Georgia State University
2012-2014

Emory University
2014

Activators of innate immunity may have the potential to combat a broad range infectious agents. We report that treatment with bacterial flagellin prevented rotavirus (RV) infection in mice and cured chronically RV-infected mice. Protection was independent adaptive interferon (IFN, type I II) required receptors Toll-like receptor 5 (TLR5) NOD-like C4 (NLRC4). Flagellin-induced activation TLR5 on dendritic cells elicited production cytokine interleukin-22 (IL-22), which induced protective gene...

10.1126/science.1256999 article EN Science 2014-11-13

Background. Rotavirus causes 500 000 deaths and millions of physician visits hospitalizations per year, with worse outcomes reduced vaccine efficacy in developing countries. We hypothesized that the gut microbiota might modulate rotavirus infection and/or antibody response thus potentially play a role such regional differences. Methods. The was ablated via germ-free or antibiotic approaches. Enhanced exposure to achieved low-dose dextran sodium sulfate (DSS) treatment. replication assessed...

10.1093/infdis/jiu037 article EN The Journal of Infectious Diseases 2014-01-16

Chronically undernourished children become stunted during their first 2 years and thereafter bear burdens of ill health for the rest lives. Contributors to stunting include poor nutrition exposure pathogens, parental history may also play a role. However, epigenetic impact environment on young is largely unknown. Here we show unfolding pattern histone H3 lysine 4 trimethylation (H3K4me3) in mothers living an urban slum Dhaka, Bangladesh. A chromatin modification blood cells emerges over time...

10.1073/pnas.1722125115 article EN cc-by Proceedings of the National Academy of Sciences 2018-11-12

Rotavirus (RV) infects small intestinal epithelial cells, inducing severe diarrhea in children, resulting over 500,000 deaths annually. Relatively little is known about how innate immunity contains acute infection and drives adaptive immune responses that afford complete clearance of RV protection against future infection. Hence, we examined the consequence absence MyD88, to be central immunity, a mouse model The but not combined blockade IL-1β IL-18 signaling, resulted greater infectivity,...

10.1177/1753425914547435 article EN Innate Immunity 2014-09-11

BACKGROUND: Programmatic management of TB infection is a critical component the WHO End Strategy. Interferon-gamma release assays (IGRAs) overcome some limitations tuberculin skin test, but implementation IGRA testing in low-resource settings challenging.METHODS: In this feasibility study, we evaluated performance novel digital lateral-flow assay, QIAreach® QuantiFERON® (QIAreach-QFT) against QuantiFERON®-TB Gold Plus (QFT-Plus) assay. A population with mix risk factors for (111 donors) were...

10.5588/ijtld.21.0391 article EN cc-by The International Journal of Tuberculosis and Lung Disease 2021-10-23

In 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a global pandemic. Disease diagnosis, appropriate clinical management and infection control are all important factors in controlling the spread of SARS-CoV-2. The QIAreach™ Anti-SARS-CoV-2 Total Test (Anti-CoV2) is rapid, qualitative serological test, using proprietary nanoparticle fluorescence technology to detect total antibody (IgA, IgM, IgG) against Here we report results US Food Drug Administration (FDA)...

10.1016/j.jcv.2020.104681 article EN cc-by-nc-nd Journal of Clinical Virology 2020-10-31
Coming Soon ...